1. 1813 Interaction of TP53 mutations with trastuzumab in HER2-positive patients with operable breast cancer. (September 2015) Authors: Kotoula, V.; Zagouri, F.; Alexopoulou, Z.; Gogas, H.; Lakis, S.; Pentheroudakis, G.; Bobos, M.; Papadopoulou, K.; Tsolaki, E.; Skondra, M.; Karavasilis, V.; Koutras, A.; Chrisafi, S.; Christodoulou, C.; Papakostas, P.; Linardou, H.; Markopoulos, C.; Zografos, G.; Samantas, E.; Fountzilas, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 183PIntrinsic tumor features underlying clinical subtype discordance in early breast cancer. (18th September 2017) Authors: Kotoula, V.; Giannoulatou, E.; Papadopoulou, K.; Tikas, I.; Manousou, K.; Bobos, M.; Lakis, S.; Lazaridis, G.; Efstratiou, I.; Zagouri, F.; Pentheroudakis, G.; Gogas, H.; Christodoulou, C.; Koutras, A.; Psyrri, A.; Papandreou, C.; Papakostas, P.; Bafaloukos, D.; Pectasides, D.; Fountzilas, G. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1976 Significance of PIK3CA mutations in patients with early breast cancer treated with adjuvant chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) study. (September 2015) Authors: Papaxoinis, G.; Kotoula, V.; Alexopoulou, Z.; Charalambous, E.; Zagouri, F.; Timotheadou, E.; Gogas, H.; Pentheroudakis, G.; Koutras, A.; Christodoulou, C.; Bafaloukos, D.; Aravantinos, G.; Kalogeras, K.T.; Pectasides, D.; Fountzilas, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2608 A retrospective study of vascular thromboembolic events (VaTEs) in patients receiving first line treatment for advanced urothelial cancer (AUC). (September 2015) Authors: Dimitriadis, I.; Tsironis, G.; Tzannis, K.; Koutsoukos, K.; Kostouros, E.; Liontos, M.; Lykka, M.; Trajce, E.; Nikolopoulos, K.; Sfika, A.; Kafantari, E.; Zagouri, F.; Matsouka, C.; Dimopoulos, M.A.; Bamias, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial. (8th May 2017) Authors: Bamias, A.; Gibbs, E.; Khoon Lee, C.; Davies, L.; Dimopoulos, M.; Zagouri, F.; Veillard, A.-S.; Kosse, J.; Santaballa, A.; Mirza, M. R.; Tabaro, G.; Vergote, I.; Bloemendal, H.; Lykka, M.; Floquet, A.; Gebski, V.; Pujade-Lauraine, E. Journal: Annals of oncology Issue: Volume 28:Number 8(2017) Page Start: 1842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cell-free DNA concentration in patients with different molecular subtypes of breast cancer. (November 2022) Authors: Karathanasis, P.; Bletsa, G.; Tsakogiannis, D.; Zografos, C.; Zagouri, F.; Zografos, G.; Michalopoulos, N. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Current clinical practice guidelines on chemotherapy and radiotherapy for the treatment of non-metastatic muscle-invasive urothelial cancer: A systematic review and critical evaluation by the Hellenic Genito-Urinary Cancer Group (HGUCG). Issue 1 (January 2015) Authors: Zagouri, F.; Peroukidis, S.; Tzannis, K.; Kouloulias, V.; Bamias, A.; on behalf of the Hellenic Genito-Urinary Cancer Group (HCUCG) Journal: Critical reviews in oncology/hematology Issue: Volume 93:Issue 1(2015) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Genetic variability of the HPV16 early genes and LCR. Present and future perspectives. (1st December 2021) Authors: Bletsa, G.; Zagouri, F.; Amoutzias, G. D.; Nikolaidis, M.; Zografos, E.; Markoulatos, P.; Tsakogiannis, D. Journal: Expert reviews in molecular medicine Issue: Volume 23(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer. (April 2021) Authors: Rugo, H.; O'Shaughnessy, J.; Song, C.; Broom, R.; Gumus, M.; Yamashita, T.; San Antonio, B.; Shahir, A.; Zimmermann, A.; Zagouri, F.; Reinisch, M. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SUN-LB040: Overweight, Obesity and Risk of Non-Hodgkin Lymphoma: A Meta-Analysis of Cohort Studies. (September 2015) Authors: Psaltopoulou, T.; Sergentanis, T.N.; Ntanasis-Stathopoulos, I.; Tzanninis, I.-G.; Zagouri, F.; Karadimitris, A. Journal: Clinical nutrition Issue: Volume 34(2015)Supplement 1 Page Start: S249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗